Court filings show pharmaceutical giant Johnson & Johnson has agreed to pay $7.8 million to settle a lawsuit over how the company marketed an antipsychotic drug to Arkansas doctors.
The Arkansas Democrat-Gazette reported $2 million will go to a Texas law firm that represented Arkansas in the suit, which began more than seven years ago.
A Pulaski County jury ruled three years ago that the company, through its Janssen Pharmaceutical subsidiary, committed Medicaid fraud and violated a state law in its labeling and marketing of Risperdal. A $1.2 billion fine was imposed on Johnson & Johnson, but it was later overturned by the Arkansas Supreme Court.
Janssen representative Michelle Bauer said Monday that the settlement isn’t an admission of liability.
Was this article valuable?
Here are more articles you may enjoy.
As Rates Rise, Majority of Homeowners Say Insurance Industry Is in Crisis: Survey 
US Home Insurance Still Priced Too Low for Climate Risk, Says Swiss Re Chair 
GEICO Tops Progressive With Higher J.D. Power Scores 
‘Extremely Dangerous’ Hurricane Beryl Takes Aim at Caribbean 
